Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2/glycolysis pathway

Bibliographic Data

ID14745804
AuthorsZiyang Lin (0000-0001-7228-6851, Guangdong Pharmaceutical University), Hongyan Huo (Guangdong Pharmaceutical University), Minyi Huang (0000-0003-1145-5281, Guangdong Pharmaceutical University), Jie Tao (0000-0002-1444-8709, Guangdong Pharmaceutical University), Yiqi Yang (0000-0002-0116-3827, Guangdong Pharmaceutical University, corresponding author), Jiao Guo (0000-0002-8519-8559, Guangdong Pharmaceutical University, corresponding author)
Year2024
Volume335
Pages118698
Publication date2024-12-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2024.118698
PMID39151712
OpenAlexW4401560336
LanguageEN
Citations received1
References cited31

Tools

Open DOI